We are live on ! Find out more
TARA icon

Protara Therapeutics
TARA

45 hedge funds and large institutions have $141M invested in Protara Therapeutics in 2015 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 15 increasing their positions, 6 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 6

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

11% more capital invested

Capital invested by funds: $126M → $141M (+$14.4M)

2% more funds holding

Funds holding: 44 → 45 (+1)

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

Holders
45
Holders Change
+1
Holders Change %
+2.27%
% of All Funds
1.18%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.1%
New
3
Increased
15
Reduced
6
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
+$352K
2
Principal Financial Group
Principal Financial Group
Iowa
+$114K
3
BFA
BlackRock Fund Advisors
California
+$79.2K
4
State Street
State Street
Massachusetts
+$72.2K
5
TRCT
Tower Research Capital (TRC)
New York
+$57.5K

Top Sellers

Rank Fund Capital Flow
1
TAM
Tiverton Asset Management
Delaware
-$1.04M
2
RCM
RA Capital Management
Massachusetts
-$439K
3
MIM
Monashee Investment Management
Massachusetts
-$206K
4
BA
BlackRock Advisors
Delaware
-$25.2K
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$11K
Name Holding Trade Value Shares
Change 		Change in
Stake
PPCM
26
Pillar Pacific Capital Management
California
$178K – – –
TA
27
Teachers Advisors
New York
$175K – – –
Charles Schwab
28
Charles Schwab
California
$171K – – –
New York State Common Retirement Fund
29
New York State Common Retirement Fund
New York
$110K – – –
Morgan Stanley
30
Morgan Stanley
New York
$106K +$54.6K +93 +121%
NFA
31
Nationwide Fund Advisors
Ohio
$75K – – –
AIG
32
American International Group
New York
$70K – – –
TRCT
33
Tower Research Capital (TRC)
New York
$61K +$57.5K +98 New
SO
34
STRS Ohio
Ohio
$57K +$17.6K +30 +48%
BA
35
BlackRock Advisors
Delaware
$52K -$25.2K -43 -34%
Citigroup
36
Citigroup
New York
$36K +$34K +58 New
Deutsche Bank
37
Deutsche Bank
Germany
$29K -$2.93K -5 -9%
Fuller & Thaler Asset Management
38
Fuller & Thaler Asset Management
California
$26K +$25.2K +43 New
BNP Paribas Financial Markets
39
BNP Paribas Financial Markets
France
$21.2K -$2.35K -4 -11%
UBS Group
40
UBS Group
Switzerland
$17K +$12.3K +21 +300%
ARMC
41
American Research & Management Company
Massachusetts
$16K – – –
Wells Fargo
42
Wells Fargo
California
$12K +$10.6K +18 +1,800%
Bank of America
43
Bank of America
North Carolina
$3K +$2.35K +4 +400%
HR
44
Howe & Rusling
New York
$1K – – –
Manulife (Manufacturers Life Insurance)
45
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$24 – – –
Royal Bank of Canada
46
Royal Bank of Canada
Ontario, Canada
– -$11K -19 Closed
Barclays
47
Barclays
United Kingdom
– -$1K -1 Closed
1
2

TARA Hedge Fund Activity: Q4 2015 in Review

45 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Protara Therapeutics (TARA) for Q4 2015, worth a combined $141M — up 11% from $126M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new TARA positions and 2 closed out — a net gain of 1 holder — while 15 added to existing stakes and 6 trimmed.

The largest buyer was Baker Bros. Advisors, adding an estimated $352K. The largest seller was Tiverton Asset Management, cutting an estimated $1.04M.

  • 45 institutional investors held Protara Therapeutics (TARA) as of Q4 2015, up from 44 in Q3 2015.
  • Funds reported $141M of Protara Therapeutics stock for Q4 2015, up 11% quarter-over-quarter.
  • 3 funds opened new Protara Therapeutics positions in Q4 2015 and 2 closed out, a net change of +1 holder.
  • The largest Protara Therapeutics buyer in Q4 2015 was Baker Bros. Advisors, an estimated $352K added.
  • The largest Protara Therapeutics seller in Q4 2015 was Tiverton Asset Management, an estimated $1.04M sold.

Based on aggregated 13F filings for Q4 2015.